For Immediate Release
Contact: Jeanne Thomson
847.836.3330
jthomson@logica3.com
Logica3 Designs Annual Report for Technology Company Celebrating 20-Year Anniversary
West Dundee, IL—April 26, 2004—CTI Molecular Imaging, Inc., selected Logica3 to design its milestone 2003 annual report celebrating 20 years as the industry leader in the development and advancement of positron emission tomography (PET) technologies in the global marketplace.
The theme of the annual report, “Twenty Years of Innovation—Twenty Years of Success—One Clear Vision of the Future,” highlights CTI's successful progression of developing breakthrough technologies used in the detection and diagnosis of cancer, neurological disorders and cardiac disease. CTI's technologies have grown rapidly as a valuable, life-saving, diagnostic tool for hospitals and outpatient diagnostic centers.
“We are very proud of our company's rich history of innovation, leadership and growth,” said Michael Lawless, Senior Director of Investor Relations for CTI. “The annual report eloquently explains how we are building on our past accomplishments to create a more dynamic future investment opportunity for our shareholders, potential investors and the investment community.”
“Logica3 did an exceptional job of crafting a clever theme for the annual report that bridges the successes of our past to our vision and strategies for future growth. They make an extra effort to fully understand our markets and technology, as well as understand and address the financial and investor goals associated with producing our annual report,” stated Lawless.
“CTI is truly an innovative and forward-looking company," said Lisa Page Dombrowski, President of Logica3, “Our goal was to create an annual report that positions CTI as a proven, successful company that has built the foundation for a prosperous future.”